Back to Search
Start Over
The relationship between COVID-19 and hyperglycemia: screening and monitoring hospitalized patients.
- Source :
-
Clinical diabetes and endocrinology [Clin Diabetes Endocrinol] 2024 Aug 31; Vol. 10 (1), pp. 29. Date of Electronic Publication: 2024 Aug 31. - Publication Year :
- 2024
-
Abstract
- Background: Elevated blood glucose concentration, also known as hyperglycemia, has been identified as a significant factor influencing the prognosis of COVID-19, alongside the impact of the SARS-CoV-2 infection itself.<br />Methods: This research is a cross-sectional investigation that examined the relationship between COVID-19 and hyperglycemia in patients admitted to Afzalipour Hospital in Kerman, Iran, from July to September 2021. A standardized data sheet was used to capture demographic data (age, gender) and laboratory information (blood sugar, arterial blood oxygen saturation, and C-reactive protein (CRP)) upon admission.<br />Results: The present research evaluated a total of 300 individuals diagnosed with COVID-19, with an average age of 50.19 ± 15.55 years. Among these patients, the majority were male, accounting for 51.67% of the total. Hyperglycemia was seen in 21.67% of patients, but less than 20% had new-onset diabetes. Individuals exhibiting hyperglycemia were typical of advanced age (P < 0.001). Furthermore, there was a slight but statistically significant association between advanced age and elevated blood glucose concentration (R = 0.254, P < 0.001). Gender had no significant impact on the occurrence of hyperglycemia (P = 0.199). There was no significant association between CRP levels and blood glucose concentration (P = 0.524) or the incidence of hyperglycemia (P = 0.473). Although there was no significant disparity in blood oxygen saturation between individuals with or without hyperglycemia (P = 0.06), higher blood glucose concentration was correlated with lower blood oxygen saturation (R = -0.151, P < 0.001).<br />Conclusion: Considering the correlation between blood glucose concentration, advanced age, and disease severity, it is recommended to carefully screen and monitor all COVID-19 patients for hyperglycemia and new-onset diabetes. Effective management of these complications could enhance the control of patients' overall prognosis and subsequent complications.<br /> (© 2024. The Author(s).)
Details
- Language :
- English
- ISSN :
- 2055-8260
- Volume :
- 10
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Clinical diabetes and endocrinology
- Publication Type :
- Academic Journal
- Accession number :
- 39215344
- Full Text :
- https://doi.org/10.1186/s40842-024-00184-7